다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc (HOWL) 뉴스

HOWL

Werewolf Therapeutics (HOWL)

Werewolf Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HOWL

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/29	05:27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/25	08:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/25	08:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/25	08:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/25	08:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/24	06:00	GlobeNewswire Inc.	Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/05/03	20:00	GlobeNewswire Inc.	Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/04/24	23:05	GlobeNewswire Inc.	Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/04/23	21:00	GlobeNewswire Inc.	Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/04/06	05:30	GlobeNewswire Inc.	Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/04/05	05:30	GlobeNewswire Inc.	Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/07	21:22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/07	21:15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/07	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/07	21:00	GlobeNewswire Inc.	Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/06	22:00	GlobeNewswire Inc.	Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/03/06	06:30	GlobeNewswire Inc.	Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2024	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/02/10	06:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/02/10	06:35	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/08	22:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	09:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	09:13	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	06:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	06:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	06:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOWL	Werewolf Therapeutics Inc
2024/01/05	06:05	GlobeNewswire Inc.	Werewolf Therapeutics Appoints Michael Atkins, M.D., to its Board of Directors	NASDAQ:HOWL	Werewolf Therapeutics Inc
2023/11/22	21:00	GlobeNewswire Inc.	Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference	NASDAQ:HOWL	Werewolf Therapeutics Inc
2023/11/15	06:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOWL	Werewolf Therapeutics Inc

검색 관련기사 보기:NASDAQ:HOWL

1 2 3 4 5 6 다음 >>

Illumina Inc Dl 01

Direxion NASDAQ 100 Equa...

American Funds College 2...

Wt S&p500 5x St

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관